MedPath

Efficacy of oral erdosteine ??in patients with acute rhinosinusitis

Not Applicable
Completed
Conditions
Diseases of the respiratory system
Registration Number
KCT0004649
Lead Sponsor
Inha University Hospital
Brief Summary

Please refer to the research result upload file.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion criteria
Diagnosis standard for acute sinusitis
? One or more of the symptoms of nasal obstruction/nasal discharge/posterior nasal drip
? One or more symptoms of sinus pain/Pressure or hyposmia/anosmia
? Observation of purulent discharge and mucous membrane edema
? Symptom duration less than 12 weeks

Exclusion Criteria

Exclusion criteria
(1) Condra-indication for Erdosteine treatment
? Patient with severe liver failure/ liver cirrhosis, patient with enzyme deficiency related to metionine metabolism
? Patients with severe renal failure
? Patient with peptic ulcer
? Pregnancy/lactating women
(2) A history of nose surgery within the last three months
(3) Chronic sinusitis and nasal polyp identified by nasal endoscopy, X-ray, CT, etc.
(4) Subjects who participated in other clinical trials within one month prior to participating in this clinical trial
(5) Subjects deemed inappropriate for participation in this study by the investigator

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom improvement(VAS score: nasal congestion, rhinorrhea, facial tenderness pain, hyposmia);improvement in nose symptom (SNOT-22 score)
Secondary Outcome Measures
NameTimeMethod
improvement of endoscopic findings;improvement of simple paranasal X-ray findings
© Copyright 2025. All Rights Reserved by MedPath